Improved High-Quality Draft Genome Sequence and Annotation of Burkholderia contaminans LMG 23361(T).

PubWeight™: 0.80^‹?›

🔗 View Article (PMID 28428315)

Published in Genome Announc on April 20, 2017

Authors

Ji Young Jung¹, Youngbeom Ahn¹, Ohgew Kweon¹, John J LiPuma², David Hussong³, Bernard S Marasa⁴, Carl E Cerniglia⁵

Author Affiliations

1: Division of Microbiology, National Center for Toxicological Research, U.S. Food and Drug Administration, Jefferson, Arkansas, USA.
2: Department of Pediatrics and Communicable Diseases, University of Michigan, Ann Arbor, Michigan, USA.
3: ValSource, LLC, Downingtown, Pennsylvania, USA.
4: Division of Microbiology Assessment, Office of Pharmaceutical Quality, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland, USA.
5: Division of Microbiology, National Center for Toxicological Research, U.S. Food and Drug Administration, Jefferson, Arkansas, USA carl.cerniglia@fda.hhs.gov.

Articles citing this ↘

High-Quality Draft Genome Sequence of Burkholderia contaminans CH-1, a Gram-Negative Bacterium That Metabolizes 2-Azahypoxanthine, a Plant Growth-Regulating Compound. Genome Announc (2017) 0.75

Articles cited by this ↗

Burkholderia cepacia: medical, taxonomic and ecological issues. J Med Microbiol (1996) 4.11

Taxon K, a complex within the Burkholderia cepacia complex, comprises at least two novel species, Burkholderia contaminans sp. nov. and Burkholderia lata sp. nov. Int J Syst Evol Microbiol (2009) 2.61

Diversity of the Burkholderia cepacia complex and implications for risk assessment of biological control strains. Annu Rev Phytopathol (2001) 2.01

Outbreak of bacteremia due to Burkholderia contaminans linked to intravenous fentanyl from an institutional compounding pharmacy. JAMA Intern Med (2014) 1.61

Environmental Burkholderia cepacia complex isolates in human infections. Emerg Infect Dis (2007) 1.36

Outbreaks associated with contaminated antiseptics and disinfectants. Antimicrob Agents Chemother (2007) 1.23

Outbreak of subclinical mastitis in a flock of dairy sheep associated with Burkholderia cepacia complex infection. J Clin Microbiol (2001) 1.01

Increase in isolation of Burkholderia contaminans from Spanish patients with cystic fibrosis. Clin Microbiol Infect (2014) 1.01

Incidence of Burkholderia contaminans at a cystic fibrosis centre with an unusually high representation of Burkholderia cepacia during 15 years of epidemiological surveillance. J Med Microbiol (2015) 0.99

Multistate outbreak of Burkholderia cenocepacia colonization and infection associated with the use of intrinsically contaminated alcohol-free mouthwash. Chest (2007) 0.97

Hospital-wide outbreak of Burkholderia contaminans caused by prefabricated moist washcloths. J Hosp Infect (2011) 0.94

Draft Genome Sequences of Burkholderia contaminans, a Burkholderia cepacia Complex Species That Is Increasingly Recovered from Cystic Fibrosis Patients. Genome Announc (2015) 0.87

The first reported case of Burkholderia contaminans in patients with cystic fibrosis in Ireland: from the Sargasso Sea to Irish Children. BMC Pulm Med (2016) 0.82

Intrinsic Resistance of Burkholderia cepacia Complex to Benzalkonium Chloride. MBio (2016) 0.79

Articles by these authors ⇆

Intrinsic Resistance of Burkholderia cepacia Complex to Benzalkonium Chloride. MBio (2016) 0.79

Erratum for Kweon et al., "Substrate Specificity and Structural Characteristics of the Novel Rieske Nonheme Iron Aromatic Ring-Hydroxylating Oxygenases NidAB and NidA3B3 from Mycobacterium vanbaalenii PYR-1". MBio (2020) 0.75